220 related articles for article (PubMed ID: 26204514)
1. Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.
Foureaux G; Franca JR; Nogueira JC; Fulgêncio Gde O; Ribeiro TG; Castilho RO; Yoshida MI; Fuscaldi LL; Fernandes SO; Cardoso VN; Cronemberger S; Faraco AA; Ferreira AJ
PLoS One; 2015; 10(7):e0133149. PubMed ID: 26204514
[TBL] [Abstract][Full Text] [Related]
2. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
PLoS One; 2014; 9(4):e95461. PubMed ID: 24788066
[TBL] [Abstract][Full Text] [Related]
3. Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.
Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4296-306. PubMed ID: 23702784
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854
[TBL] [Abstract][Full Text] [Related]
5. Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SOA; Cronemberger S; Nogueira JC; Ferreira AJ; Faraco AAG
Int J Pharm; 2019 Oct; 570():118662. PubMed ID: 31491481
[TBL] [Abstract][Full Text] [Related]
6. Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis.
Zheng C; Lei C; Chen Z; Zheng S; Yang H; Qiu Y; Lei B
Mol Vis; 2015; 21():403-11. PubMed ID: 25883526
[TBL] [Abstract][Full Text] [Related]
7. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.
Coutinho DC; Monnerat-Cahli G; Ferreira AJ; Medei E
Europace; 2014 Nov; 16(11):1689-96. PubMed ID: 24741027
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.
Macedo LM; Souza ÁP; De Maria ML; Borges CL; Soares CM; Pedrino GR; Colugnati DB; Santos RA; Mendes EP; Ferreira AJ; Castro CH
Life Sci; 2016 Jun; 155():63-9. PubMed ID: 27153779
[TBL] [Abstract][Full Text] [Related]
9. Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats.
De Maria ML; Araújo LD; Fraga-Silva RA; Pereira LA; Ribeiro HJ; Menezes GB; Shenoy V; Raizada MK; Ferreira AJ
Protein Pept Lett; 2016; 23(1):9-16. PubMed ID: 26458404
[TBL] [Abstract][Full Text] [Related]
10. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT
Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB
Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122
[TBL] [Abstract][Full Text] [Related]
11. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
Badae NM; El Naggar AS; El Sayed SM
Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489
[TBL] [Abstract][Full Text] [Related]
12. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
[TBL] [Abstract][Full Text] [Related]
13. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation.
Velkoska E; Patel SK; Burrell LM
Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):384-95. PubMed ID: 27367913
[TBL] [Abstract][Full Text] [Related]
15. The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.
Castardeli C; Sartório CL; Pimentel EB; Forechi L; Mill JG
Biomed Pharmacother; 2018 Nov; 107():212-218. PubMed ID: 30092400
[TBL] [Abstract][Full Text] [Related]
16. New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study.
Cesar ALA; Navarro LC; Castilho RO; Goulart GAC; Foureaux G; Ferreira AJ; Cronemberger S; Gomes Faraco AA
J Biomed Mater Res A; 2021 Mar; 109(3):336-345. PubMed ID: 32490596
[TBL] [Abstract][Full Text] [Related]
17. Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model.
Dhawale VS; Amara VR; Karpe PA; Malek V; Patel D; Tikoo K
Toxicol Appl Pharmacol; 2016 Sep; 306():17-26. PubMed ID: 27343405
[TBL] [Abstract][Full Text] [Related]
18. Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.
Velkoska E; Patel SK; Griggs K; Burrell LM
PLoS One; 2016; 11(8):e0161760. PubMed ID: 27571511
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme 2 activator, DIZE in the basolateral amygdala attenuates the tachycardic response to acute stress by modulating glutamatergic tone.
Silva CC; Correa AMB; Kushmerick C; Sharma NM; Patel KP; de Almeida JFQ; Moreira FA; Ferreira AJ; Fontes MAP
Neuropeptides; 2020 Oct; 83():102076. PubMed ID: 32800589
[TBL] [Abstract][Full Text] [Related]
20. Diminazene aceturate improves autonomic modulation in pulmonary hypertension.
Rigatto K; Casali KR; Shenoy V; Katovich MJ; Raizada MK
Eur J Pharmacol; 2013 Aug; 713(1-3):89-93. PubMed ID: 23665493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]